Login

Interview with Genasys CEO Richard S. Danforth on company developments and industry insights. 00:10:00

Share On Facebook Share On Twitter

Richard S. Danforth is the CEO of Genasys.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Endeavor Silver: Powering Growth with Taranera Project
00:10:00
America's Gold and Silver: Expanding Production Across North America
00:10:00
Reflecting on Ardian's Milestones and Commitment in 2021 | Dominique Senequier, President, Ardian.
00:10:00
Catalyst Metals Targets 200K Oz Annual Gold Production with Strategic Acquisitions
00:10:00
Discussion on Challenges, Brzeszcze Mine Acquisition, and Market Trends with Vice-President of TAURON Polska Energia SA | Marek Wadowski, Vice-President ,Tauron Polska Energia SA.
00:10:00
A career at Leclanché offers opportunities in the energy storage industry, focusing on innovative battery solutions and sustainable energy technologies.
00:10:00
Tarek Müller's 2024 E-Commerce Trends: AI, Cross-Border Expansion, and Influencer Marketing | Tarek Müller, Founder , ABOUT YOU Holding SE.
00:10:00
The Book of Mormon: Dialogic Revelation and Christian Beliefs in the Western Hemispher|Terryl Givens,Professor,University of Richmond
00:10:00
Exploring Innovations in Learning and Curriculum Development
00:10:00
BIO-key's Periodic SEC Filings Offer Comprehensive Insights into Cybersecurity Expansion and Business Performance | Michael DePasquale, CEO, BIO-key International Inc.
00:10:00
Bokusgruppen's CEO Maria Edsman Discuss Q4 Performance, Challenges, and Future Strategies | Maria Edsman, CEO, Bokusgruppen AB.
00:10:00
Insights from Shemara's Three-Decade Journey at Macquarie Group |Shemara Wikramanayake , CEO, Macquarie Group.

© 2017 - Neuhu+